Flavin-containing monooxygenase 3 gene polymorphisms in Turkish population

References

• Cashman JR. 2004. The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and development. Drug Discov Today 9:574–581.
   PubMed Web of Science ®Google Scholar
• Cashman JR, Zhang J. 2002. Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation. Drug Metab Dispos 30:1043–1052.
   PubMed Web of Science ®Google Scholar
• Cashman JR, Zhang J. 2006. Human flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol 46:65–100.
   PubMed Web of Science ®Google Scholar
• Cashman JR, Zhang J, Leushner J, Braun A. 2001. Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms. Drug Metab Dispos 29:1629–1637.
   PubMed Web of Science ®Google Scholar
• Daly AK, Steen VM, Fairbrother KS, Idle JR. 1996. CYP2D6 multiallelism. Meth Enzymol 272:199–210.
   PubMed Web of Science ®Google Scholar
• Dolphin CT, Riley JH, Smith RL, Shephard EA, Phillips IR. 1997. Structural organization of the human flavin-containing monooxygenase 3 gene (FMO3), the favored candidate for fish-odor syndrome, determined directly from genomic DNA. Genomics 46:260–267.
   PubMed Web of Science ®Google Scholar
• Hao DC, Sun J, Furnes B, Schlenk D, Hou ZF, Zhang YP, Yang SL, Yang L. 2006. Haplotype frequency distribution and linkage disequilibrium analysis of single nucleotide polymorphisms at the human FMO3 gene locus. Biochem Genet 44:391–407.
   Google Scholar
• Hao D, Sun J, Furnes B, Schlenk D, Li M, Yang S, Yang L. 2007. Allele and genotype frequencies of polymorphic FMO3 gene in two genetically distinct populations. Cell Biochem Funct 25:443–453.
   Google Scholar
• Hernandez D, Addou S, Lee D, Orengo C, Shephard EA, Phillips IR. 2003. Trimethylaminuria and a human FMO3 mutation database. Hum Mutat 22:209–213.
   PubMed Web of Science ®Google Scholar
• Hernandez D, Janmohamed A, Chandan P, Phillips IR, Shephard EA. 2004. Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters. Pharmacogenetics 14:117–130.
   PubMedGoogle Scholar
• Hisamuddin IM, Wehbi MA, Chao A, Wyre HW, Hylind LM, Giardiello FM, Yang VW. 2004. Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis. Clin Cancer Res 10:8357–8362.
   PubMed Web of Science ®Google Scholar
• Kang JH, Chung WG, Lee KH, Park CS, Kang JS, Shin IC, Roh HK, Dong MS, Baek HM, Cha YN. 2000. Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FM03 gene mutations in a Korean population. Pharmacogenetics 10:67–78.
   PubMedGoogle Scholar
• Koukouritaki SB, Hines RN. 2005. Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development. Pharmacogenomics 6:807–822.
   PubMed Web of Science ®Google Scholar
• Koukouritaki SB, Poch MT, Henderson MC, Siddens LK, Krueger SK, VanDyke JE, Williams DE, Pajewski NM, Wang T, Hines RN. 2007. Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants. J Pharmacol Exp Ther 320:266–273.
   PubMed Web of Science ®Google Scholar
• Koukouritaki SB, Simpson P, Yeung CK, Rettie AE, Hines RN. 2002. Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression. Pediatr Res 51:236–243.
   PubMed Web of Science ®Google Scholar
• Krueger SK, Williams DE. 2005. Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 106:357–387.
   PubMed Web of Science ®Google Scholar
• Lambert DM, Mamer OA, Akerman BR, Choinière L, Gaudet D, Hamet P, Treacy EP. 2001. In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene. Mol Genet Metab 73:224–229.
   PubMed Web of Science ®Google Scholar
• Lattard V, Zhang J, Tran Q, Furnes B, Schlenk D, Cashman JR. 2003. Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies. Drug Metab Dispos 31:854–860.
   PubMed Web of Science ®Google Scholar
• Lomri N, Gu Q, Cashman JR. 1992. Molecular cloning of the flavin-containing monooxygenase (form II) cDNA from adult human liver. Proc Natl Acad Sci USA 89:1685–1689.
   PubMed Web of Science ®Google Scholar
• Mayatepek E, Flock B, Zschocke J. 2004. Benzydamine metabolism in vivo is impaired in patients with deficiency of flavin-containing monooxygenase 3. Pharmacogenetics 14:775–777.
   PubMedGoogle Scholar
• Overby LH, Carver GC, Philpot RM. 1997. Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans. Chem Biol Interact 106:29–45.
   PubMed Web of Science ®Google Scholar
• Park CS, Kang JH, Chung WG, Yi HG, Pie JE, Park DK, Hines RN, McCarver DG, Cha YN. 2002. Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities. Pharmacogenetics 12:77–80.
   PubMedGoogle Scholar
• Phillips IR, Francois AA, Shephard EA. (2007). The flavin-containing monooxygenases (FMOs): genetic variation and its consequences for the metabolism of therapeutic drugs. Curr Pharmacogenomics, 5, 292–313.
   Google Scholar
• Poetsch M, Czerwinski M, Wingenfeld L, Vennemann M, Bajanowski T. 2010. A common FMO3 polymorphism may amplify the effect of nicotine exposure in sudden infant death syndrome (SIDS). Int J Legal Med 124:301–306.
   PubMed Web of Science ®Google Scholar
• Sachse C, Ruschen S, Dettling M, Schley J, Bauer S, Müller-Oerlinghausen B, Roots I, Brockmöller J. 1999. Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism. Clin Pharmacol Ther 66:431–438.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Yano H, Nagashima S, Murayama N, Zhang J, Cashman JR, Yamazaki H. 2007. Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities. Drug Metab Dispos 35:328–330.
   PubMed Web of Science ®Google Scholar
• Stephens M, Donnelly P. 2003. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169.
   PubMed Web of Science ®Google Scholar
• Störmer E, Roots I, Brockmöller J. 2000. Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity. Br J Clin Pharmacol 50:553–561.
   PubMed Web of Science ®Google Scholar
• Yeung CK, Lang DH, Thummel KE, Rettie AE. 2000. Immunoquantitation of FMO1 in human liver, kidney, and intestine. Drug Metab Dispos 28:1107–1111.
   PubMed Web of Science ®Google Scholar
• Zhou J, Shephard EA. 2006. Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3. Mutat Res 612:165–171.
   PubMed Web of Science ®Google Scholar